Evidence map›Paper›PMID 37409241›Full record

ArticleInfection and drug resistance2023

Refractory

Manon Levêque, Nadim Cassir, Fanny Mathias, Cindy Fevre, Florence Daviet, Julien Bermudez, Geoffrey Brioude, Florence Peyron, Martine Reynaud-Gaubert, Benjamin Coiffard

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Infection and drug resistance, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Unlocking the Potential ofMicroorganisms · 2025
    Article
  4. Phage therapy: breathing new tactics into lower respiratory tract infection treatments.European respiratory review : an official journal of the European Respiratory Society · 2024
    Review
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Manon LevêqueDepartment of Respiratory Medicine and Lung Transplantation, APHM, Aix Marseille University, Hôpital Nord, Marseille, France.ORCID 0009-0002-2512-7158
Nadim CassirDepartment of Infectious Disease, APHM, IHU Méditerranée Infection, Aix-Marseille University, Marseille, France.
Fanny MathiasDepartment of Pharmacy, APHM, Aix Marseille University, Hôpital Nord, Marseille, France.
Cindy FevreResearch and Development, Pherecydes Pharma, Romainville, France.
Florence DavietIntensive Care Medicine, APHM, Aix Marseille University, Hôpital Nord, Marseille, France.
Julien BermudezDepartment of Respiratory Medicine and Lung Transplantation, APHM, Aix Marseille University, Hôpital Nord, Marseille, France.
Geoffrey BrioudeDepartment of Thoracic Surgery and Lung Transplantation, APHM, Aix Marseille University, Hôpital Nord, Marseille, France.
Florence PeyronDepartment of Pharmacy, APHM, Aix Marseille University, Hôpital Nord, Marseille, France.
Martine Reynaud-GaubertDepartment of Respiratory Medicine and Lung Transplantation, APHM, Aix Marseille University, Hôpital Nord, Marseille, France.
Benjamin CoiffardDepartment of Respiratory Medicine and Lung Transplantation, APHM, Aix Marseille University, Hôpital Nord, Marseille, France.ORCID 0000-0002-8896-5346
Aix-Marseille Université · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recipients transplanted for bronchiectasis in the context of a primary immune deficiency, such as common variable immunodeficiency, are at a high risk of severe infection in post-transplantation leading to poorer long-term outcomes than other transplant indications. In this report, we present a fatal case due to chronic

Indexed as

immunoglobulin therapylung transplantationphage therapyprimary immunodeficiency diseasesPseudomonas aeruginosa

Identifiers

PMID37409241
PMCPMC10319284
OpenAlexW4382601368

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.